Science

Heidi Overton withdrawn as Trump pick to lead the FDA

Heidi Overton withdrawn as Trump pick to lead the FDA


Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of health care. Confidential tips can be sent on Signal at danielp.100.

WASHINGTON — The Trump administration is pulling its nominee to lead the Food and Drug Administration, Heidi Overton, according to a White House official and a source close to Overton. 

The decision follows concerns that Overton, a preventive care doctor who served in the Trump White House, lacked sufficient support from Republicans on the Senate’s health panel, which had been expected to vote on her nomination Wednesday. However, late on Tuesday, the panel’s leader, Sen. Bill Cassidy (R-La.), said Overton had sufficient support to clear his committee and win confirmation.

“Tonight, the White House abandoned a viable confirmation path for Dr. Overton,” Cassidy said in a post on X.

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe



Source link